GF/B37/DP12
Approved by the Board on: 04 May 2017
Amended and Restated Global Fund Quality Assurance Policy for Diagnostic Products
Based on the recommendation of the Strategy Committee, the Board approves the amended and restated Global Fund Quality Assurance Policy for Diagnostic Products, as set forth in Annex 1 to GF/B37/06.